Delivery Order SPE2DB22D1106-SPE2DB25FDVV6

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,649,540 units of Febuxostat 40 mg tablets. The Firm Fixed Price delivery order, valued at $1,222.02, has a ceiling of $1,222.02 and a period of performance through February 14, 2024. The contract does not have a set-aside designation, indicating open competition. This award is likely part of a larger Indefinite Delivery Contract (IDC)...
The federal contract award, SPE2DB20D3505|SPE2DB22FT9R2, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.59 delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of Febuxostat 40 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of June 28, 2022. This award is associated with Amerisourcebergen's...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DB20D1100|SPE2DB25FC2J2, is a delivery order for the supply of 40 mg Febuxostat tablets. The contract has a ceiling value of $1,232.56 and is a firm fixed-price contract with a completion date of May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, SPE2DB20D1100|SPE2DB25FC0C9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,182.78 firm fixed-price delivery order is for the supply of 4,568,076,011 units of the medication Febuxostat 40 mg tablets. The contract has an ultimate completion date of April 30, 2025 and was awarded on April 29, 2025. This award is not associated with a set-aside program....
This federal contract award, SPE2DB22D1106|SPE2DB25FECG4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,725.09 firm fixed-price delivery order is for the supply of febuxostat 40 mg tablets to support military healthcare programs. The award is associated with AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FG0XA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,185.79 firm fixed-price delivery order is for the supply of 4,568,013,055 units of the drug Febuxostat 40 mg tablets. The contract has an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.52 firm fixed-price delivery order is for the supply of 4567557705 ! FEBUXOSTAT 40 MG TABLET 30S. The contract has an ultimate completion date of March 13, 2025 and was awarded on March 12, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DB24D1034|SPE2DB24FVXX4, is for the delivery of Febuxostat 40 mg tablets in 30-count packages. The contract has a fixed-price, delivery order structure with a ceiling value of $5,031.64 and a period of performance through February 12, 2024. This award is not designated as a set-aside...
This federal contract award is for the delivery of Febuxostat 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,631.04, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,358.43 firm fixed-price delivery order is for the supply of 4559470354 - Febuxostat 40 mg Tablets, 30s. The award has an ultimate completion date of December 30, 2022 and was made on December 29, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDVV6
    Delivery Order

This federal contract award, SPE2DB22D1106|SPE2DB25FDVV6, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of Febuxostat 40 mg tablets. The contract has a ceiling value of $1,485.26 and a completion date of January 27, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 9:48 AM